Reza Nekouian | Genetics and Molecular Biology | Pioneer Researcher Award

Published on by Citation Awards

Reza Nekouian | Genetics and Molecular Biology | Pioneer Researcher Award

Dr Reza Nekouian, Iran University of Medical Sciences, IUMS, Iran

Dr. Reza Nekouian, a seasoned faculty member at Iran University of Medical Sciences, brings over 17 years of expertise in cancer genetics and molecular diagnostics. Born on March 21, 1978, in Tehran, Iran, he has built a strong reputation in research design, academic teaching, and innovative cancer research solutions. Known for his problem-solving and leadership skills, Dr. Nekouian excels in guiding research teams and translating molecular findings into clinical applications. His academic contributions span across cancer genetics, molecular biology, and personalized medicine. In addition to being a dedicated educator in medical genetics and genetic engineering, he is also widely published in reputable journals. Dr. Nekouian is recognized for his collaborative spirit, exceptional communication, and passion for scientific innovation. His work significantly impacts early cancer detection and personalized treatments, aligning science with real-world health solutions.

Publication Profile

google scholar

Education

Dr. Reza Nekouian received his Ph.D. in Medical Biotechnology from Pune University, India, in 2007, where he specialized in cancer molecular biology and therapeutics. Prior to that, he completed his Master of Science (M.Sc.) in Health Sciences (Genetics) at the University of Pune in 2003. His academic journey reflects a focused pursuit of excellence in biotechnology and genetics, laying the foundation for his later contributions in cancer research and medical education. His studies in India exposed him to a rich scientific environment and equipped him with the latest tools in molecular genetics and biomedical research. These formative years nurtured his deep interest in translational medicine, setting him on a path to combine lab-based innovations with clinical cancer diagnostics. Dr. Nekouian’s educational background continues to fuel his research on biomarkers, cancer therapeutics, and molecular diagnostics, making him a valuable contributor to the global scientific and medical community.

Experience

Dr. Reza Nekouian has served as a faculty member and researcher at Iran University of Medical Sciences (IUMS) since February 2012. His core responsibilities include designing and managing cutting-edge research projects in cancer genetics, molecular diagnostics, and biomarker development for early cancer detection. He also actively contributes to advancing personalized medicine approaches in oncology. As a dedicated educator, Dr. Nekouian teaches theoretical and practical courses in medical genetics and genetic engineering, inspiring the next generation of scientists and clinicians. His professional journey spans over 17 years of impactful work at medical universities and research centers. He is recognized for his skill in resolving complex genetic and molecular research challenges, leading multidisciplinary teams, and publishing groundbreaking findings. With a focus on translational research, he bridges laboratory innovations with patient-centric medical applications, thereby improving diagnostic precision and therapeutic strategies in cancer treatment.

Awards and Honors

Although specific awards are not listed in the profile, Dr. Reza Nekouian’s extensive contributions to cancer genetics, personalized medicine, and molecular diagnostics have earned him academic distinction and professional recognition across Iranian and international research communities. His consistent publication in reputed journals, leadership in high-impact research, and role in educational development underscore his influence in the field. Dr. Nekouian has been instrumental in pioneering research programs and contributing to national strategies for cancer prevention and diagnosis. His invited roles in collaborative projects, advisory panels, and journal editorial activities serve as implicit recognition of his expertise. He is regularly consulted for complex research problem-solving and project development, particularly in molecular biology and biotechnology. Additionally, his leadership in implementing cancer control initiatives in the private health sector highlights his commitment to both scientific excellence and societal health advancement.

Research Focus

Dr. Reza Nekouian’s research centers on cancer genetics, with a specialized focus on the molecular mechanisms of tumorigenesis and biomarker discovery for early detection. His work explores the genetic regulation of cancer progression, using advanced diagnostic tools like circulating microRNAs and liposomal drug delivery systems. He also investigates personalized medicine approaches, including the role of gene expression and polymorphisms in cancer susceptibility and therapeutic response. A recurring theme in his research is the integration of molecular diagnostics with clinical oncology, aiming to improve diagnostic accuracy and treatment precision. Dr. Nekouian has contributed significantly to breast, gastric, and colorectal cancer research, evaluating biomarkers like miRNAs, HLA-G, and FOXP3, and exploring innovative cancer therapies using viral vectors and nanotechnology. His interdisciplinary approach blends molecular biology, bioinformatics, and pharmacogenomics to enhance patient outcomes and reduce cancer mortality through early, personalized interventions.

Publication Top Notes

📄 Evaluation of the in vitro and in vivo effect of liposomal doxorubicin with Newcastle disease virus on 4T1 cell line (2023)
📄 Plasma miR-183-5p as a predictive lymph node metastasis marker in colorectal cancer (2022)
📄 Effect of testosterone enanthate on liver Irs-2 mRNA expression in PCOS model rats (2021)
📄 Meta-analysis of serum HLA-G level accuracy in breast cancer diagnosis (2020)
📄 Expression of angiogenesis-related genes in Iranian breast cancer patients (2020)
📄 Epidemiological study of postsurgical invasive breast cancer cases in Iran (2020)
📄 Use of software in detecting angiogenesis in breast tissue slides (2020)
📄 Meta-analysis of FOXP3 polymorphisms and multiple sclerosis susceptibility (2020)
📄 Evaluation of miR-21 and miR-222 as diagnostic biomarkers for gastric cancer (2019)
📄 Nanocomposite scaffold with MSCs for bone repair applications (2019)
📄 Study on protein-binding malondialdehyde in breast cancer tissues (2019)
📄 Management of biotechnology industry in the West and solutions for Iran (2018)
📄 In vitro effects of Lactobacillus reuteri on gastric cancer progression (2017)
📄 Implementation of private sector cancer prevention programs in Iran (2017)
📄 Study on BRCA1/2 mutations in women with breast cancer family history (2016)
📄 Anti-fibronectin gold nanoparticle biosensor for ECM detection (2014)
📄 Iranian consumers’ shift to functional foods for healthier lifestyle (2014)
📄 FOXP3 mRNA downregulation by Alkanna Frigida extract (2013)
📄 H-semigroup structure on F-offspring of a gene pool (2012)

Anna Lankoff | Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Anna Lankoff | Genetics and Molecular Biology | Best Researcher Award

Prof Anna Lankoff, Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Poland

Prof. Anna Lankoff is a distinguished scientist and educator renowned for her contributions to genotoxicology, nanotoxicology, and radiobiology. 👩‍🔬🧪 With over three decades of experience, she has made groundbreaking advancements in the study of ionizing radiation-induced DNA damage, nanoparticle-based radioconjugates for cancer therapy, and cellular responses to nanomaterials. 🌐🔬 Currently, she holds full professorships at both the Institute of Nuclear Chemistry and Technology in Warsaw and Jan Kochanowski University in Kielce, where she leads the Cytogenetics and Genotoxicology Laboratories. 💡📘 Her collaborative work spans across institutions in Germany, Finland, Belgium, and the USA. She is a respected academic leader, actively participating in global expert committees including WHO-IARC and the European Radiation Research Council. 🌍📚 With 85 peer-reviewed papers, 3797 citations, and an h-index of 30, Prof. Lankoff exemplifies excellence in research and education, making her an ideal candidate for the Best Researcher Award. 🏆🔝

Publication Profile

Orcid

Education 

Prof. Anna Lankoff began her academic journey with an MSc in Biology (1986–1991) from Jan Kochanowski University, Kielce, Poland. 🎓🔬 She earned her PhD in Toxicology in 1999 from Maria Sklodowska-Curie University in Lublin, Poland. 💊📘 Her research prowess led her to complete a prestigious postdoctoral fellowship in 2003 at Wright State University in Dayton, Ohio, USA, in the Department of Biological Sciences. 🌍🧬 In 2007, she achieved her DSc (habilitation) in Biological Sciences from the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences. 🧫📖 By 2014, she was awarded the title of Full Professor in Biological Sciences, marking a significant milestone in her academic career. 🌟 Her extensive academic preparation laid the foundation for a prolific scientific and educational path in radiobiology, cytogenetics, and nanotoxicology. 🧠💼

Experience 

Prof. Lankoff has an extensive academic and research career. Since 2014, she has been a Full Professor at both the Institute of Nuclear Chemistry and Technology, Warsaw, and Jan Kochanowski University, Kielce. 🧪🇵🇱 She leads laboratories in cytogenetics and genotoxicology. From 2009–2014, she served as Associate Professor at these institutions, and previously, as a lecturer and assistant since 1991. 📘👩‍🏫 Her international experience includes research stints at University of Duisburg-Essen (Germany), Wright State University (USA), VITO (Belgium), and Åbo Akademi University (Finland). 🌐🔍 She has mentored numerous students and professionals in molecular biology, immunology, and nanotoxicology. Her professional journey reflects dedication to excellence in both teaching and cutting-edge scientific research. 💡🧬

Awards and Honors 

Prof. Anna Lankoff’s contributions have been recognized internationally. 🌟 She was a working group member for the WHO-IARC (2006) and an expert for the EU’s “Epigenetic effects” radiation protection group (2017). 🌍🔬 She represented Poland on the ISO Radiology Standards Committee (2010–2015) and serves on the Scientific Council of the Institute of Nuclear Chemistry and Technology and the Polish Society for Radiation Research. 🇵🇱📘 She is also a member of the European Radiation Research Council since 2022. 🧪💡 Her work has earned her recognition for developing standards in biological dosimetry and contributions to nanotoxicology and radiation biology. 📜🔝 With a prolific academic record of 85 JCR-listed publications and over 3,700 citations, she holds an h-index of 30. 📚 Her impactful global collaborations, editorial work, and advisory roles highlight her as a true leader in radiobiological research and innovation. 🧬🏆

Research Focus 

Prof. Lankoff’s research integrates nanotechnology, radiobiology, and molecular biology. 🧬 Her focus areas include the genotoxicity and cytotoxicity of nanomaterials, development of nanoparticle-based radioconjugates for targeted cancer diagnosis and therapy, and the mechanisms of DNA damage and repair induced by ionizing radiation. 💥🧪 She investigates cellular responses such as cell cycle arrest, apoptosis, and pyroptosis in reaction to nanomaterial exposure and radiation treatment. 🧫 Her recent work explores nanotheranostics, blackcurrant-derived antioxidants, and radiosensitization strategies using natural compounds. 🌿💉 She also delves into biodistribution, pharmacokinetics of engineered nanostructures, and radiobiological safety, bridging basic science with translational medicine. 🌐🧠 Prof. Lankoff’s innovative research contributes to the development of safer nanomaterials and more effective cancer therapies, reinforcing her status as a pioneering researcher in modern molecular and radiation biology. 🧪🔬📈

Publication Top Notes

  1. 📘 Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years (2024)

  2. 🧪 Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer (2023)

  3. ☢️ Hypothermia Modulates NBS1, γH2AX and 53BP1 Foci in U2OS Cells Post Gamma Radiation (2022)

  4. 🍇 Blackcurrant Pomace Protects Rats from Testicular Oxidative Stress from Biodiesel Exhaust (2022)

  5. 🔬 Surface Modification of Gold Nanoparticles Triggers Pyroptosis-Inducing Cytokine Release (2022)

  6. 💉 Targeted NaA Nanozeolites for Prostate Cancer Therapy: Toxicity and Pharmacokinetics (2021)

  7. 🧬 Cisplatin Lowers Radiotherapy-Induced Micronuclei in Lymphocytes of Gynaecological Cancer Patients (2021)

  8. 📈 Coralyne Radiosensitizes A549 Cells by CDKN1A Upregulation Affecting G2/M Cell Cycle Arrest (2021)

 

Abimbola Arise | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Published on by Citation Awards

Abimbola Arise | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Dr. Abimbola Arise, University of Ilorin, Kwara State, Nigeria

Dr. Abimbola Kemisola Arise (née Jayeoba) is an esteemed researcher and academic in Food Science and Technology. Born on July 5, 1977, she currently serves in the Department of Home Economics and Food Science. She began her academic career as an Assistant Lecturer in 2011 and has since contributed significantly to food research, focusing on food safety, protein characterization, and product development. A dedicated scholar, she has published extensively in international journals and authored book chapters on sensory evaluation and functional food properties. Dr. Arise is a passionate mentor and an active member of multiple professional societies, including the Nigerian Institute of Food Science and Technology (NIFST) and the South African Association for Food Science and Technology. She has also received awards for her outstanding research contributions. Her expertise in food biochemistry and technology continues to impact both academia and industry.

Publication Profile

google scholar

Education 🎓

Dr. Abimbola Kemisola Arise (née Jayeoba) is an esteemed researcher and academic in Food Science and Technology. Born on July 5, 1977, she currently serves in the Department of Home Economics and Food Science. She began her academic career as an Assistant Lecturer in 2011 and has since contributed significantly to food research, with a focus on food safety, protein characterization, and product development. A dedicated scholar, she has published extensively in international journals and authored book chapters on sensory evaluation and functional food properties. Dr. Arise is a passionate mentor and an active member of multiple professional societies, including the Nigerian Institute of Food Science and Technology (NIFST) and the South African Association for Food Science and Technology. She has also received awards for her outstanding research contributions. Her expertise in food biochemistry and technology continues to impact both academia and industry, fostering advancements in nutritional science, product innovation, and food safety standards.

Experience

Dr. Arise has over a decade of experience in academia and food research. She joined the University of Ilorin as an Assistant Lecturer in 2011 and has progressed through the ranks due to her research excellence. Her career has been dedicated to teaching and mentoring students in Food Science and Technology, with a strong emphasis on applied research and industry collaboration.She has led multiple research projects focusing on food safety, functional food development, and protein characterization. Dr. Arise also participates in peer review activities, contributing as a reviewer for reputable scientific journals. Beyond academia, she engages with professional organizations and has presented her findings at international and national conferences.Her experience extends to supervising undergraduate and postgraduate students, developing innovative food products, and collaborating with industry professionals to advance food processing and safety standards in Nigeria and beyond.

Awards & Honors

  • 🥇 Best Poster Presenter Award – NIFST Conference, University of Ilorin (2019)

  • 🎖️ Member, Nigerian Women in Agriculture Research & Development (2019–Present)

  • 🎖️ Member, Nigerian Society of Experimental Biology (NISEB) (2013–Present)

  • 🎖️ Member, South African Association for Food Science and Technology (2014–Present)

  • 🎖️ Member, Nigerian Institute of Food Science and Technology (NIFST) (2011–Present)

Dr. Arise has been recognized for her impactful research, securing the Best Poster Award at the 2019 NIFST Conference. She is a distinguished member of several professional bodies, contributing to advancements in food science through research, mentorship, and collaborations. Her professional affiliations reflect her commitment to scientific excellence and continuous learning in the field.

Research Focus

Dr. Abimbola Kemisola Arise’s research primarily focuses on food biochemistry, functional food development, and protein extraction. She specializes in protein characterization and the functional properties of legumes, particularly exploring alternative protein sources such as Bambara groundnut 🥜. Her work in fortified and enriched food products 🌿 aims to enhance nutritional quality, while her expertise in sensory evaluation and consumer acceptability 🍪 ensures that innovative food products meet consumer preferences. She also investigates food preservation and safety techniques 🧫 to improve shelf life and reduce spoilage. Additionally, her research delves into nutritional profiling and the health benefits of indigenous foods 📉, providing insights into their potential role in public health. Dr. Arise’s studies on Moringa-enriched maize flour, Bambara groundnut proteins, and food storage techniques have contributed significantly to functional food science. She is committed to bridging the gap between scientific innovation and practical food solutions, promoting sustainable food processing technologies to minimize waste and maximize nutrient retention.

Publication Top Notes

📝 Journals

1️⃣ Effects of storage conditions and periods on glycoalkaloids content and nutritional value of Solanum tuberosum – Journal of Agricultural Research and Development (2012)
2️⃣ Acceptability and Nutritional Attributes of Moringa oleifera–enriched maize flour – Journal of Agricultural Research and Development (2012)
3️⃣ The effects of addition of moringa leaf waste fibre on proximate and sensory characteristics of cookies – Agrosearch (2013)
4️⃣ Acceptability and sensory characteristics of moringa leaf and moringa-based species in Kwara State – International Journal of Phytofuel and Allied Sciences (2014)
5️⃣ Proximate composition, functional and sensory properties of “TUWO” from maize and Bambara groundnut – Applied Tropical Agriculture (2019)
6️⃣ Comparative studies on amino acid and functional properties of black benniseed and false sesame protein concentrates – Ajayi Crowther Journal of Pure and Applied Sciences (2024)

📖 Book Chapters

7️⃣ Understanding Sensory Evaluation of Food – Food Science and Technology, Walter De Gruyter STEM (2021)
8️⃣ Bambara Groundnut Protein in Food and Potential Industrial Applications – Springer (2021)

Santina Bruzzone | Genetics and Molecular Biology | Best Researchers Award

Published on by Citation Awards

Santina Bruzzone | Genetics and Molecular Biology | Best Researchers Award

Santina Bruzzone,Università di Genova,Italy

Santina Bruzzone is a Full Professor of Biochemistry at the University of Genova, Italy. She was born on February 21, 1972, in Genova, Italy. Her research focuses on the role of NAD+ and NAD+-converting enzymes in inflammation and cancer.

Publication Profile

Scopus

Education

Santina Bruzzone completed her high school education at Liceo Scientifico L. Lanfranconi in Genova, Italy, from 1986 to 1991. She then earned her degree in Biology from the University of Genova, graduating cum laude with a score of 110/110 in 1996. She received her Ph.D. in Biotechnology applied to Pharmacology and Cellular and Molecular Biotechnology applied to Biomedicine from the University of Milano from 1996 to 2000.

Experince

Santina Bruzzone worked as a postdoctoral researcher at the Department of Experimental Medicine (DIMES)–Section of Biochemistry, University of Genova, from January to March 2001. She then worked as a postdoctoral researcher at the Department of Pharmacology, University of Minnesota, from April to December 2001. She returned to the University of Genova as a postdoctoral researcher from 2002 to 2005 and later became an Assistant Professor of Biochemistry from 2005 to 2016. She was promoted to Associate Professor of Biochemistry from 2016 to 2021 and became a Full Professor of Biochemistry in 2021.

Award and Honors

Santina Bruzzone received several awards and honors, including the Fellowship for training abroad from Consorzio Interuniversitario Biotecnologie (CIB) in 2001, the Fellowship for training abroad from the University of Genova in 2001, and the Faculty Research Visit Grant from DAAD (German Academic Exchange Service) in 2013.

Research Focus

Santina Bruzzone’s research focuses on the role of NAD+ and NAD+-converting enzymes in inflammation and cancer. Her work explores the molecular mechanisms underlying the regulation of NAD+ metabolism and its impact on cellular processes such as energy metabolism, cell signaling, and cell death.

Publications

1. 🌟 CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the Calcium-mobilizing activity of Cyclic ADP-ribose. (1997)
2. 🌟 Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-mobilizing activity of Cyclic ADP-ribose. (1998)
3. 🌟 Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. (1998)
4. 🌟 The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger Cyclic ADPribose across membranes. (1998)
5. 🌟 Dimeric and tetrameric forms of catalytically active transmembrane CD38 in transfected HeLa cells. (1998)
6. 🌟 Ligand-induced internalization of CD38 results in intracellular Ca2+ mobilization. (1999)
7. 🌟 Topology of CD38. (2000)
8. 🌟 Extracellular cyclic ADP-ribose increases intracellular free calcium concentration and stimulates proliferation of human hemopoietic progenitors. (2000)
9. 🌟 G(s) protein dysfunction in allergen-challenged human isolated passively sensitized bronchi. (2000)
10. 🌟 Connexin 43 hemichannels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. (2001)
11. 🌟 Extracellular Cyclic ADP-ribose potentiates Ach-induced contraction in bovine tracheal smooth muscle. (2001)
12. 🌟 Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. (2001)
13. 🌟 Paracrinally stimulated expansion of early human hemopoietic progenitors by stroma-generated cyclic ADP-ribose. (2001)
14. 🌟 Paracrine roles of NAD+ and Cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. (2001)
15. 🌟 Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes. (2012)
16. 🌟 ABA says NO to UV-B: a universal

Juan Ribas | Molecular Biology | Best Research Article Award

Published on by Citation Awards

Dr. Juan Ribas | Molecular Biology | Best Research Article Award

 

Laboratory Manager at Spanish National Research Council, Spain

Dr. Juan Carlos Ribas Elcorobarrutia is a distinguished researcher specializing in microbiology and functional genomics, particularly focusing on yeast biology. His research spans various aspects of yeast cell wall synthesis, β-glucan metabolism, and antifungal resistance mechanisms. Dr. Ribas has made significant contributions to understanding yeast morphogenesis, cytokinesis, and cell division processes, emphasizing their implications for cell integrity and growth regulation. His work includes the development of regulatable autolytic yeast strains for biotechnological applications and exploring molecular mechanisms in fungal cell wall dynamics. Dr. Ribas has a robust publication record and has presented extensively at international conferences, showcasing his commitment to advancing microbiological knowledge and its applications.

Professional Profiles:

📚 Education:

Dr. Juan Carlos Ribas Elcorobarrutia holds a robust academic background in biology, having earned his Bachelor’s degree and subsequently his Doctorate in Biology from the University of Salamanca. His educational journey began with a Bachelor’s degree in Biology, which he completed with distinction, receiving recognition for his academic achievements. Following this, Dr. Ribas pursued doctoral studies at the same institution, successfully defending his thesis in Biology, which marked a significant milestone in his academic career.                        Throughout his educational tenure, Dr. Ribas demonstrated a strong commitment to biological sciences, focusing particularly on the intricate mechanisms of yeast biology. His doctoral research and subsequent postdoctoral experiences at prominent institutions such as the National Institutes of Health (NIH) in the USA contributed substantially to his expertise in virology and yeast cell wall biosynthesis. Dr. Ribas’s educational background not only provided him with a solid foundation in biological sciences but also equipped him with the necessary skills and knowledge to excel in his subsequent research and academic endeavors. His educational achievements underscore his dedication to advancing scientific knowledge, particularly in the fields of microbiology and functional genomics, where he continues to make significant contributions through his research and professional engagements.

Professional Experience:

Dr. Juan Carlos Ribas Elcorobarrutia has accumulated a wealth of experience in the field of biological research and academia throughout his career. His professional journey includes various roles in research, teaching, and scientific leadership, primarily centered around microbiology and functional genomics. Dr. Ribas began his scientific career as an intern at the IMB, a joint center of the CSIC and the University of Salamanca, where he gained foundational experience in microbiological research. He then progressed to a predoctoral fellowship under the PFPI-MEC program, focusing on yeast biology and cell wall synthesis, topics that would become central to his research interests. Following the completion of his doctoral studies, Dr. Ribas embarked on a postdoctoral research period at the prestigious National Institutes of Health (NIH) in the United States. Here, he deepened his expertise in virology and molecular biology, particularly in understanding the mechanisms of viral infections in yeast. Upon returning to Spain, Dr. Ribas continued his career trajectory at the IMB as an Assistant Professor under the LRU scheme and subsequently secured positions as a postdoctoral researcher and later as a Research Scientist under various contracts and grants. His research during these years focused on yeast genetics, cell biology, and the development of novel antifungal strategies based on cell wall synthesis inhibition.

Honors and Awards:

Dr. Juan Carlos Ribas Elcorobarrutia has garnered several honors and awards throughout his illustrious career in microbiology and functional genomics. His notable achievements reflect his significant contributions to scientific research and leadership in the field. Dr. Ribas was recognized early in his academic journey with the prestigious Extraordinary Doctorate Award from the University of Salamanca in 1990, underscoring his outstanding doctoral research contributions. His excellence in research was further acknowledged by the CSIC, where he received the CSIC Award in 2015, highlighting his impact and leadership within the scientific community. In addition to these formal accolades, Dr. Ribas has been the recipient of multiple grants and fellowships that have supported his research endeavors, including predoctoral and postdoctoral awards from institutions such as the Spanish Ministry of Education and the NIH in the United States. These grants not only facilitated his research on yeast virology and cell wall synthesis but also enabled him to foster international collaborations and expand the frontiers of scientific knowledge. Dr. Ribas’s honors and awards underscore his dedication to advancing microbiological research and his commitment to excellence in scientific inquiry. His contributions continue to be recognized both nationally and internationally, solidifying his reputation as a leader in the field of functional genomics and microbiology.

Research Interest:

Dr. Juan Carlos Ribas Elcorobarrutia has made significant contributions to the field of microbiology and functional genomics through his pioneering research endeavors. His research focuses primarily on yeast biology, with particular emphasis on cell wall synthesis, β-glucan metabolism, and antifungal resistance mechanisms. Throughout his career, Dr. Ribas has explored fundamental aspects of yeast morphogenesis, cytokinesis, septation, and cell division, shedding light on critical processes that govern yeast cell integrity and growth. A prominent area of Dr. Ribas’s research involves the development of regulatable autolytic yeast strains for the expression of heterologous proteins, offering innovative solutions in biotechnological applications. His studies on the molecular mechanisms underlying β-glucan synthesis and its regulation have contributed significantly to our understanding of fungal cell wall dynamics and have implications for antifungal drug development.

📚Publications :

In vitro antifungal evaluation and structure–activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers …

Authors: SN Lopez, MV Castelli, SA Zacchino, JN Domınguez, G Lobo, …

Citations: 438

Year: 2001

Isolation and characterization of Saccharomyces cerevisiae mutants resistant to Calcofluor white

Authors: C Roncero, MH Valdivieso, JC Ribas, A Duran

Citations: 192

Year: 1988

In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers

Authors: MV Castelli, VV Kouznetsov, SN López, M Sortino, RD Enriz, JC Ribas, …

Citations: 178

Year: 2003

Localization of the (1, 3) β-D-glucan synthase catalytic subunit homologue Bgs1p/Cps1p from fission yeast suggests that it is involved in septation, polarized growth, mating …

Authors: JCG Cortés, J Ishiguro, A Durán, JC Ribas

Citations: 172

Year: 2002

The novel fission yeast (1, 3) β-D-glucan synthase catalytic subunit Bgs4p is essential during both cytokinesis and polarized growth

Authors: JCG Cortés, E Carnero, J Ishiguro, Y Sánchez, A Durán, JC Ribas

Citations: 164

Year: 2005

Decoying the Cap2 mRNA Degradation System by a Double-Stranded RNA Virus and Poly(A)2 mRNA Surveillance by a Yeast Antiviral System

Authors: DC Masison, A Blanc, JC Ribas, K Carroll, N Sonenberg, RB Wickner

Citations: 163

Year: 1995

cps1+, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B

Authors: J Ishiguro, A Saitou, A Duran, JC Ribas

Citations: 146

Year: 1997

The (1,3)β‐d‐glucan synthase subunit Bgs1p is responsible for the fission yeast primary septum formation

Authors: JCG Cortés, M Konomi, IM Martins, J Muñoz, MB Moreno, M Osumi, …

Citations: 137

Year: 2007

Inhibitors of the fungal cell wall. Synthesis of 4-aryl-4-N-arylamine-1-butenes and related compounds with inhibitory activities on β (1–3) glucan and chitin synthases

Authors: JM Urbina, JCG Cortés, A Palma, SN López, SA Zacchino, RD Enriz, …

Citations: 132

Year: 2000

The fungal cell wall as a target for the development of new antifungal therapies

Authors: JCG Cortés, MÁ Curto, VSD Carvalho, P Pérez, JC Ribas

Citations: 116

Year: 2019